Ocular delivery of cyclosporine A using dissolvable microneedle contact lens

[1]  Xiaoyu Sui,et al.  The Effect of PVP Molecular Weight on Dissolution Behavior and Physicochemical Characterization of Glycyrrhetinic Acid Solid Dispersions , 2020 .

[2]  M. Jurak,et al.  Cyclosporine CsA—The Physicochemical Characterization of Liposomal and Colloidal Systems , 2020, Colloids and Interfaces.

[3]  F. Otero-Espinar,et al.  Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations , 2020, Pharmaceutics.

[4]  D. Monti,et al.  Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A , 2020, Pharmaceutics.

[5]  P. Garg,et al.  Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis. , 2019, International journal of pharmaceutics.

[6]  J. Choi,et al.  The Efficiency of Cyclosporine A-Eluting Contact Lenses for the Treatment of Dry Eye , 2019, Current eye research.

[7]  Chenjie Xu,et al.  Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery , 2018, Nature Communications.

[8]  M. Martín-Pastor,et al.  Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation , 2018, International journal of pharmaceutics.

[9]  I. Tekko,et al.  Microneedles for Ocular Drug Delivery and Targeting: Challenges and Opportunities , 2018, Microneedles for Drug and Vaccine Delivery and Patient Monitoring.

[10]  Rinda Devi Bachu,et al.  Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases , 2018, Pharmaceutics.

[11]  M. Sridhar,et al.  Anatomy of cornea and ocular surface , 2018, Indian journal of ophthalmology.

[12]  Shubhmita Bhatnagar,et al.  Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles , 2018, Drug Delivery and Translational Research.

[13]  Kaushalkumar Dave,et al.  Microneedles in the clinic. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[14]  R. Gurny,et al.  Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  David S. Jones,et al.  Minimally invasive microneedles for ocular drug delivery , 2017, Expert opinion on drug delivery.

[16]  H. McCarthy,et al.  Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery , 2016, Drug Delivery and Translational Research.

[17]  Ryan F. Donnelly,et al.  Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development , 2016 .

[18]  S. Karakus,et al.  Frequent Dosing of Topical Cyclosporine A for Severe Ocular Surface Disease. , 2016, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[19]  Ting Liu,et al.  Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation , 2015, Scientific Reports.

[20]  Su-Eon Jin,et al.  Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method , 2014, International journal of nanomedicine.

[21]  Maelíosa T. C. McCrudden,et al.  The role of microneedles for drug and vaccine delivery , 2014, Expert opinion on drug delivery.

[22]  G. Campbell,et al.  Indentation and needle insertion properties of the human eye , 2014, Eye.

[23]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[24]  F. Lallemand,et al.  Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb , 2012, Journal of drug delivery.

[25]  Guojun Zhang,et al.  Hydrogel Contact Lens for Extended Delivery of Ophthalmic Drugs , 2011 .

[26]  E. Denkbaş,et al.  Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[27]  D. Dallatana,et al.  Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability , 2009, Molecular vision.

[28]  A. Czogalla,et al.  Oral cyclosporine A - the current picture of its liposomal and other delivery systems , 2008, Cellular & Molecular Biology Letters.

[29]  J. Prause,et al.  Corneal Thickness in Pigs Measured by Ultrasound Pachymetry In Vivo , 2008 .

[30]  M. Prausnitz,et al.  Coated microneedles for drug delivery to the eye. , 2007, Investigative ophthalmology & visual science.

[31]  Anuj Chauhan,et al.  Ophthalmic drug delivery through contact lenses. , 2004, Investigative ophthalmology & visual science.

[32]  R. Gurny,et al.  Cyclosporine A delivery to the eye: a pharmaceutical challenge. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  Craig Boote,et al.  Collagen fibrils appear more closely packed in the prepupillary cornea: optical and biomechanical implications. , 2003, Investigative ophthalmology & visual science.

[34]  D. K. Majumdar,et al.  Permeation through cornea. , 2001, Indian journal of experimental biology.

[35]  M. Doughty,et al.  Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. , 2000, Survey of ophthalmology.

[36]  P. Sado,et al.  Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.

[37]  R. Nussenblatt,et al.  Side effects of systemic cyclosporine in patients not undergoing transplantation. , 1984, The American journal of medicine.